Ventilator-Associated Pneumonia (VAP) Market driven by Awareness towards Hospital Acquired Infection, Global Trends by 2023

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Ventilator-associated pneumonia (VAP) Market over the forecast period.

Pune, India - June 10, 2019 /MarketersMedia/ —

Global Ventilator-Associated Pneumonia (VAP) Market Overview

Ventilator-associated pneumonia refers to a type of lung infection caused due to lung disease, trauma to critically ill patients or neurological disease. VAP diagnosis requires aggressive surveillance coupled with a radiographic examination, microbiological examinations, and bedside examinations of respiratory secretions. The global ventilator-associated pneumonia market is estimated to witness ascension at a lucrative rate, as stated in the latest report published by Market Research Future (MRFR). Many factors are pushing the global ventilator-associated pneumonia market during the forecast period.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1377

Some factors driving the global ventilator-associated pneumonia market include the growing ICU  admissions due to rising prevalence of respiratory diseases, increasing number of ICU beds and a high incidence of traumatic injuries. As per the CDC in 2013, there are about 2.8 million traumatic brain injury visits to emergency departments and hospitals. These emergency department visits for brain injury patients have increased by 47% since 2007.

 Further, a rapidly growing geriatric population is estimated to push the global ventilator-associated pneumonia market to a great extent through the assessment period.  In 2015, conferring to the U.S. Census Bureau, around 47.8 million people were 65 years or older. Even though many factors are proving to be favorable to the market growth for ventilator-associated pneumonia, some factors are expected to refrain the market from growing after a certain extent. Expensive diagnostic tests, high ventilator charges, risks associated with ventilators and inappropriate reimbursement scenario are projected to restrict market growth during the forecast timeline.

Key Players

The global ventilator-associated pneumonia (VAP) market boasts the presence of many notable players including Merck & Co., Inc. (US), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria).

Market Segmentation

The global ventilator-associated pneumonia market has been segmented on the basis of diagnosis, mode of treatment, end-users, and region for better understanding. Based on diagnosis, the global ventilator-associated pneumonia (VAP) market has been segmented into clinical examination, radiological examination, and microbiological analysis. The microbiological analysis segment is further sub-segmented into non-quantitative or semi-quantitative airway sampling, blood and pleural fluid cultures, and quantitative cultures of airway specimens.  Based on the mode of treatment, the VAP market is segmented into homecare and hospital care. Based on end-user the VAP market is segmented into research centers, ambulatory care, emergency medical services, and hospitals & clinics.

Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377

Detailed Regional Analysis

The global ventilator-associated pneumonia (VAP) market is geographically segmented into North America, South America, Europe, Asia Pacific, and the Middle East & Africa. North America and South America combined are estimated to garner the largest share in the global ventilator-associated pneumonia (VAP) market during the forecast period. Such domination can be owed to the increasing prevalence of smoking which is leading to lung diseases and a large number of patients suffering from chronic heart diseases. This is leading to a rise in the demand for mechanical ventilators driving the global ventilator-associated pneumonia (VAP) market to a great extent.

Europe is estimated to witness steady growth for ventilator-associated pneumonia (VAP) treatment through the conjectured period. Such continuous growth can be attributed to the extensive demand for medical devices in hospitals. Further, a rapid rise in the healthcare expenditure in the region is anticipated to push ventilator-associated pneumonia (VAP) market throughout the review period.

Asia Pacific is projected to showcase the fastest growth owing to the rise in the environmental pollution in the region. Also, a high incidence of asthma & chronic obstructive pulmonary disease and a large patient pool in the region are also some other factors contributing heavily to the propulsion of growth in ventilator-associated pneumonia (VAP) market. Awareness towards the prevention of hospital-acquired infections, pneumonia and quality control measures taken by hospitals for the control of nosocomial infections are likely to favor the growth in the regional market.  The Middle East & Africa are estimated to garner limited yet steady growth in ventilator-associated pneumonia (VAP) market during the review period.

Industry Update

September 2018: Melinta Therapeutics, Inc., a commercial-stage company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) had realized a positive opinion recommending Vabomere for approval as a treatment for adult patients with hospital-acquired pneumonia including ventilator-associated pneumonia.

Send and Enquiry @ https://www.marketresearchfuture.com/enquiry/1377

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377

Source URL: https://marketersmedia.com/ventilator-associated-pneumonia-vap-market-driven-by-awareness-towards-hospital-acquired-infection-global-trends-by-2023/521963

Source: MarketersMedia

Release ID: 521963